D. E. Shaw & Co., Inc. 9 Meters Biopharma, Inc. Transaction History

D. E. Shaw & Co., Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.26 - $0.64 $166,606 - $410,109	-640,796 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.52 - $1.0 $200,018 - $384,650	384,650 Added 150.17%	640,796 $384,000
Q4 2021 Feb 14, 2022	SELL	$0.85 - $1.33 $359,062 - $561,826	-422,426 Reduced 62.25%	256,146 $251,000
Q3 2021 Nov 15, 2021	SELL	$1.03 - $1.41 $13,301 - $18,208	-12,914 Reduced 1.87%	678,572 $882,000
Q2 2021 Aug 16, 2021	BUY	$1.04 - $1.5 $719,145 - $1.04 Million	691,486 New	691,486 $761,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.